In Brief: Bristol-Myers Squibb
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb: Completes acquisition of approximately 77% of Hungarian manufacturing company Pharmavit from Imre Somody and Genericon Pharma GmbH and its associates. The firm notes that its cash offer for the remaining publicly held shares amounting to over 22% of Pharmavit's capital has become unconditional, and the company now controls over 99% of Pharmavit's capital. Bristol-Myers announced the acquisition on Dec. 13 ("The Tan Sheet" Dec. 18, 1995, p. 3)...